Syncom Formulations (India) Ltd. benchmarking: Perfomance to industry peers

Financial

	Syncom Formulations	Bliss GVS Pharma	Jagsonpal Pharma
Operational Metrics
Financials
5 yr Average ROE	9.79 %	6.83 %	16.01 %
5yr average Equity Multiplier	1.41	1.3	1.27
5yr Average Asset Turnover Ratio	0.81	0.62	1.09
5yr Avg Net Profit Margin	8.78 %	8.7 %	12.08 %
Price to Book	4.57	1.56	5.96
P/E	27.18	15.36	24.79
5yr Avg Cash Conversion Cycle	61.57 Days	186.56 Days	2.39 Days
Inventory Days	27.32 Days	54.35 Days	37.29 Days
Days Receivable	82.75 Days	189.93 Days	15.63 Days
Days Payable	79.41 Days	75.78 Days	59.94 Days
5yr Average Interest Coverage Ratio	31.44	14.68	66.99
5yr Avg ROCE	13.63 %	13.27 %	18.99 %
5yr Avg Operating Profit Margin	9.97 %	17.03 %	13.23 %
5 yr average Debt to Equity	0.19	0.11	0.01
5yr CAGR Net Profit	36.24 %	4.24 %	26.54 %
5yr Average Return on Assets	7.11 %	5.31 %	12.71 %
Shareholdings
Promoter Holding	50.57 %	35.39 %	67.54 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.84 %	-1.18 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Syncom Formulations	Bliss GVS Pharma	Jagsonpal Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 98.42 Commodity 0.85 Rental Income 0.73 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Pharmaceuticals 0	Product Wise Break-Up Anti Malarials 43.0 Anti-fungal 16.0 Anti-bacterial 0 Pharmaceutical 0 Pharmaceuticals 0 Antibiotics 5.0 Anti Inflammatory 7.0 Rental Income 0 Commodity 0 Others 29.0	Product Wise Break-Up Antimalarial 0 Anti-fungal, 0 Anti-bacterial 0 Pharmaceutical 0 Pharmaceuticals 100.0 Anti-biotic 0 Anti Inflammatory 0 Rental Income 0 Commodity 0
Location Wise Break-Up	Location Wise Break-Up International 84.5 Domestic 15.5 Rest of the World 0 India 0	Location Wise Break-Up India 6.61 Rest of the World 93.39 Domestic 0 International 0	Location Wise Break-Up India 0 Rest of the World 0 India 98.7 International 0 Others 1.3
Drug Delivery Break-Up	Drug Delivery Break-Up Tablets 79.76 Injectables 6.08 Capsules 2.14 Liquids 1.82 Ointment 1.0 Dry Powder 0.49 Others 8.71	-	-
Capex	Capex Formulations 100.0 Trading of Commodities 0 Renting of Property 0	-	-
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical Drugs & Formulations 95.88 Renting of Property 4.05 Trading of Commodities 0.07	-	-
Raw Material Break-Up	Raw Material Break-Up Tapentadol Hydrochloride 53.16 Packing Material 14.34 Paracetamol 3.0 CEFTRIAXONE SODIUM 0.78 Ibuprofen 0.74 Others 27.98	-	-
Asset Break-Up	Asset Break-Up Formulations 88.85 Renting of Property 10.57 Trading of Commodities 0.58	-	-

Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd.

Financial

Business

SIGN UP FOR FREE